• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·REGN
Held by 3 Gurus
Share

Regeneron Pharmaceuticals, Inc. Stocks

$ 796.02Last Updated 24.09.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

$ 82.66B

In Guru Portfolios

Bob Prince, Greg Jensen, Karen Karniol-Tambour

Portfolio Weight (%)

0.1%

Change

+0.05%

Fund

Bridgewater Associates

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

-0.01%

Fund

CITADEL ADVISORS LLC

Steven Cohen

Portfolio Weight (%)

0.0%

Change

-0.15%

Fund

Point72 Asset Management, L.P.

Manager
Fund
Portfolio Weight (%)
Change
Bob Prince, Greg Jensen, Karen Karniol-TambourBridgewater Associates0.1%+0.05%
Kenneth GriffinCITADEL ADVISORS LLC0.0%-0.01%
Steven CohenPoint72 Asset Management, L.P.0.0%-0.15%

Trending

25.09.2026 17:31

A hedge fund with a 235% return viewed the drop in gold prices as temporary

25.09.2026 17:11

Romania borrowed $600 million from the public through the "blood-for-bonds" program

25.09.2026 16:45

Western, Barbie, and Alpine Skiing: What Will Help Wrangler's Stock Rise 50%?

25.09.2026 16:11

Shares of CareDx, a medical test developer, soared to a 5-year high. Why?

25.09.2026 15:45

"Hacker Club" Incidents: How Errors in AI Tests Created New Risks for Investors

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026